Fig. 7From: Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trialsForest plot of meta-analysis for the comparison of adverse renal events between the SGLT-2i and placebo groups. a Acute renal failure, b acute renal injuryBack to article page